$2.155
-0.005 (-0.23%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
RADX Prediction & Forecast by Similar Chart Analysis
Alphio's RADX stock price prediction model matches the current Radiopharm Theranostics Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.13 (-1.37%). The 1-week path is $2.18 (+0.94%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Radiopharm Theranostics Ltd Stock?
Radiopharm Theranostics Limited (RADX) appears to be a good buy right now due to its recent positive clinical trial results and a strong analyst price target. The stock closed at $2.41, which is significantly below the analyst's target of $6, suggesting a potential upside of 148.95%. Additionally, the stock has shown a recent increase of 6.64% in price, indicating a positive short-term momentum. However, the stock has a high forward P/E of 0 and a negative price-to-earnings ratio, which presents a risk if the clinical trials do not meet expectations.
RADX stock price ended at $2.16 on Thursday, after losing -0.23%
Radiopharm Theranostics Ltd (RADX) last closed at $2.155, losing -0.23%. These facts feed the 1-day and 1-week RADX price prediction above.
Forecast Drivers
Radiopharm Theranostics Ltd (RADX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches RADX, ranked by similarity.
Seasonality analysis for RADX
Historically the probability of a positive September return for RADX is 84.00%. October offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for RADX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $4.23 | $4.49 | $4.61 | +108.35% |
| Oct 2026 | $4.17 | $4.76 | $5.42 | +121.03% |
| Nov 2026 | $4.55 | $5.35 | $5.42 | +148.45% |
| Dec 2026 | $4.18 | $4.42 | $4.44 | +105.31% |
In 2026, Radiopharm Theranostics Ltd (RADX) is projected to range from $4.17 to $5.42.
Radiopharm Theranostics Ltd 2026 monthly forecast
In Sep 2026, Radiopharm Theranostics Ltd is projected to average $4.49, with a low of $4.23 and high of $4.61.
In Oct 2026, Radiopharm Theranostics Ltd is projected to average $4.76, with a low of $4.17 and high of $5.42.
In Nov 2026, Radiopharm Theranostics Ltd is projected to average $5.35, with a low of $4.55 and high of $5.42.
In Dec 2026, Radiopharm Theranostics Ltd is projected to average $4.42, with a low of $4.18 and high of $4.44.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.